- Home
- SNSE vs BMRA Comparison
SNSE vs BMRA Comparison
Compare SNSE & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- BMRA
- Stock Information
- Founded
- SNSE 2005
- BMRA 1971
- Country
- SNSE United States
- BMRA United States
- Employees
- SNSE N/A
- BMRA N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SNSE Health Care
- BMRA Health Care
- Exchange
- SNSE Nasdaq
- BMRA Nasdaq
- Market Cap
- SNSE 12.5M
- BMRA 11.2M
- IPO Year
- SNSE 2021
- BMRA N/A
- Fundamental
- Price
- SNSE $0.33
- BMRA $0.54
- Analyst Decision
- SNSE Strong Buy
- BMRA
- Analyst Count
- SNSE 4
- BMRA 0
- Target Price
- SNSE $4.25
- BMRA N/A
- AVG Volume (30 Days)
- SNSE 8.2M
- BMRA 181.9K
- Earning Date
- SNSE 03-28-2025
- BMRA 04-15-2025
- Dividend Yield
- SNSE N/A
- BMRA N/A
- EPS Growth
- SNSE N/A
- BMRA N/A
- EPS
- SNSE N/A
- BMRA N/A
- Revenue
- SNSE N/A
- BMRA $5,578,000.00
- Revenue This Year
- SNSE N/A
- BMRA N/A
- Revenue Next Year
- SNSE N/A
- BMRA N/A
- P/E Ratio
- SNSE N/A
- BMRA N/A
- Revenue Growth
- SNSE N/A
- BMRA 1.40
- 52 Week Low
- SNSE $0.25
- BMRA $0.24
- 52 Week High
- SNSE $1.94
- BMRA $1.27
- Technical
- Relative Strength Index (RSI)
- SNSE 34.62
- BMRA 37.83
- Support Level
- SNSE $0.25
- BMRA $0.55
- Resistance Level
- SNSE $0.76
- BMRA $0.74
- Average True Range (ATR)
- SNSE 0.07
- BMRA 0.05
- MACD
- SNSE -0.01
- BMRA -0.01
- Stochastic Oscillator
- SNSE 14.76
- BMRA 12.17
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.